Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.00
+0.0100 (0.78%)
May 1, 2026, 9:33 AM EDT - Market open
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.32 million as of May 1, 2026. Its market cap has increased by 1.13% in one year.
Market Cap
2.32M
Enterprise Value
-3.02M
1-Year Change
1.13%
Ranking
Category
Stock Price
n/a
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.32M, a decrease of -98.51%. That is a compound annual growth rate of -34.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.34M | -10.00% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Decoy Therapeutics | 2.87M |
| Oragenics | 2.77M |
| HCW Biologics | 2.76M |
| Virax Biolabs Group | 2.57M |
| Calidi Biotherapeutics | 2.53M |
| Silexion Therapeutics | 2.38M |
| Propanc Biopharma | 2.26M |
| Adial Pharmaceuticals | 2.20M |